Transferrin receptor 2 (TFR2) is a membrane-bound protein that plays a significant role in iron homeostasis, a critical process for the maintenance of cellular and systemic iron levels. TFR2 is primarily expressed in the liver and erythroid precursor cells, where it functions in concert with other proteins to regulate iron uptake and storage. Unlike its counterpart, transferrin receptor 1 (TFR1), which is ubiquitously expressed and directly involved in iron uptake by cells through the binding and internalization of transferrin-bound iron, TFR2 does not seem to play a major role in iron uptake. Instead, it has a crucial function in sensing body iron levels and modulating the activity of key regulatory proteins involved in iron metabolism, such as hepcidin. Hepcidin is a liver-produced hormone that controls iron absorption from the diet and iron release from macrophages. TFR2's interaction with hepcidin illustrates its integral role in the feedback loop that maintains iron homeostasis, ensuring that iron levels are sufficient for erythropoiesis and other physiological needs while curbing iron overload.
The activation of TFR2 is intricately linked to its ability to sense and respond to circulating iron levels, primarily through its interaction with transferrin-bound iron and its cooperation with other iron-regulatory proteins. The mechanisms of TFR2 activation involve the binding of diferric transferrin (transferrin with two iron atoms) to TFR2, which triggers signaling pathways that influence hepcidin expression. This interaction is thought to be critical in the liver's response to iron status, with TFR2 acting as a sensor for transferrin saturation and modulating hepcidin levels accordingly. Additionally, TFR2's function and activation are influenced by its oligomerization state and its interaction with other membrane proteins, including HFE (a protein associated with hereditary hemochromatosis) and transferrin receptor 1. These interactions are essential for the fine-tuning of hepcidin expression and the subsequent regulation of iron metabolism. Understanding the mechanisms underlying TFR2 activation and its role in iron homeostasis provides valuable insights into the complex regulatory networks controlling iron absorption and distribution, which are crucial for erythropoiesis and overall physiological balance.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Cobalt(II) chloride can simulate hypoxic conditions, potentially increasing HIF-mediated transcription and upregulating TFR2 expression. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper(II) sulfate can upregulate HIF-1, which in turn might increase the expression of TFR2 as part of the cellular response to maintain iron homeostasis. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
Ascorbic acid can enhance iron absorption and might upregulate TFR2 expression to increase iron uptake in conditions of increased iron demand. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
Diethylstilbestrol has been shown to affect iron metabolism, and compounds that mimic its effects might indirectly upregulate TFR2. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
These inhibitors can stabilize HIF under normoxic conditions and potentially increase TFR2 expression as part of the iron regulatory response. | ||||||
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3 | 808118-40-3 unlabeled | sc-488006 | 10 mg | $12000.00 | ||
By stabilizing HIF, FG-4592 could potentially enhance the expression of TFR2 in response to iron demand. | ||||||
MHY1485 | 326914-06-1 | sc-507522 | 10 mg | $140.00 | ||
mTOR signaling is involved in cellular growth and might influence TFR2 expression indirectly. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
PPARγ agonists can modulate gene expression and could indirectly affect TFR2 expression. | ||||||
Ammonium iron(III) citrate | 1185-57-5 | sc-227256 sc-227256A sc-227256B sc-227256C | 100 g 1 kg 5 kg 10 kg | $50.00 $84.00 $374.00 $697.00 | 2 | |
Providing a bioavailable form of iron could indirectly increase TFR2 expression to enhance iron uptake. | ||||||